Novonix (NVX) Equity Average (2021 - 2025)

Novonix (NVX) has 5 years of Equity Average data on file, last reported at $149.6 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average fell 6.92% year-over-year to $149.6 million; the trailing twelve-month figure through Dec 2025 stood at $149.6 million (down 6.92% YoY), and the FY2025 full-year result was $149.6 million, down 6.92% from the prior year.
• Equity Average for Q4 2025 stood at $149.6 million, down from $160.8 million in the prior quarter.
• Across five years, Equity Average topped out at $243.5 million in Q4 2022 and bottomed at $93.3 million in Q2 2021.
• The 5-year median for Equity Average is $181.1 million (2022), against an average of $175.6 million.
• The widest annual swing landed in 2022, when Equity Average jumped 116.04%; it then slipped 21.58% in 2024.
• A 5-year view of Equity Average shows it stood at $93.3 million in 2021, then soared by 161.11% to $243.5 million in 2022, then decreased by 15.82% to $205.0 million in 2023, then retreated by 21.58% to $160.8 million in 2024, then fell by 6.92% to $149.6 million in 2025.
• The last three Equity Average figures came in at $149.6 million (Q4 2025), $160.8 million (Q4 2024), and $205.0 million (Q4 2023), per Business Quant data.

Peer Comparison